Skip to Content

Notice

Bulk Manufacturer of Controlled Substances Application: Chemtos, LLC

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

ACTION:

Notice of application.

DATES:

Registered bulk manufacturers of the affected basic class, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration in accordance with 21 CFR 1301.33(a) on or before July 18, 2017.

ADDRESSES:

Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152.

End Preamble Start Supplemental Information

SUPPLEMENTARY INFORMATION:

The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Assistant Administrator of the DEA Diversion Control Division (“Assistant Administrator”) pursuant to section 7 of 28 CFR part 0, appendix to subpart R.

In accordance with 21 CFR 1301.33(a), this is notice that on July 5, 2016, Chemtos, LLC, 14101 W. Highway 290, Building 2000B, Austin, Texas 78737-9331 applied to be registered as a bulk manufacturer for the following basic classes of controlled substances:

Controlled substanceDrug codeSchedule
Mephedrone (4-Methyl-N-methylcathinone)1248I
Methaqualone2565I
JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl) indole)6250I
5-Flouro-UR-144 and XLR11 [1-(5-Fluoro-pentyl)1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone7011I
Start Printed Page 23069
JWH-019 (1-Hexyl-3-(1-naphthoyl)indole)7019I
JWH-018 (also known as AM678) (1-Pentyl-3-(1-naphthoyl)indole)7118I
JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl) indole)7122I
UR-144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone7144I
JWH-073 (1-Butyl-3-(1-naphthoyl)indole)7173I
Lysergic acid diethylamide7315I
2,5-Dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7)7348I
3,4-Methylenedioxyamphetamine7400I
3,4-Methylenedioxy-N-ethylamphetamine7404I
3,4-Methylenedioxymethamphetamine7405I
MDPV (3,4-Methylenedioxypyrovalerone)7535I
Methylone (3,4-Methylenedioxy-N-methylcathinone)7540I
Desomorphine9055I
Norlevorphanol9634I
Phencyclidine7471II
Dextropropoxyphene, bulk (non-dosage forms)9273II
Noroxymorphone9668II
Sufentanil9740II
Tapentadol9780II
Fentanyl9801II

The company plans to manufacture small quantities of the listed controlled substances in bulk for distribution to its customers.

Start Signature

Dated: May 15, 2017.

Louis J. Milione,

Assistant Administrator.

End Signature End Supplemental Information

[FR Doc. 2017-10231 Filed 5-18-17; 8:45 am]

BILLING CODE 4410-09-P